Abbott Plans to Spin Off Nutrition Business by 2027
The company says the separation will create a listed nutrition business and leave Abbott focused on devices, diagnostics and medicines.
Makkler Newsroom · Oct 21, 06:59 PM · 1 min read
Market closed· · USD · Data may be delayed
Avg. target $119.46 (+10.1%)
Prices may be delayed and are for informational purposes only - not investment advice.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.